Name | MEDITSINSKIY TSENTR SOVREMENNAYA TERAPIYA, ZAO |
|---|
INN | 5902244124 |
|---|
KPP | 590201001 |
|---|
OGRN | 1135902012388 |
|---|
OKPO | 26614171 |
|---|
Address | 614015, Permskiy Kray, g. Perm', ul. Okulova, d. D.18 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 86.10 | Core activity | Hospitals | | 46.46 | Additional activity | Wholesale of pharmaceutical goods | | 47.73 | Additional activity | Retailing drugs in specialized stores (pharmacies) | | All types of activities | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 86.21 | Additional activity | General practice | | 86.23 | Additional activity | Dental practice | | 86.90.9 | Additional activity | Other independent activities in health care |
Registration date | 11.12.2013 |
|---|
|
MEDITSINSKIY TSENTR SOVREMENNAYA TERAPIYA, ZAO (Perm Krai; INN 5902244124) was registered on 11 Dec 2013. The company's authorized capital as of July 1, 2012 was 100000 rub. Principal activities of MEDITSINSKIY TSENTR SOVREMENNAYA TERAPIYA, ZAO: hospitals (86.10), wholesale of pharmaceutical goods (46.46), retailing drugs in specialized stores (pharmacies) (47.73). |
Economic indicators2023
Net loss (RAS) of MEDITSINSKIY TSENTR SOVREMENNAYA TERAPIYA, ZAO dropped over 2023 6.82 times to 293.00 thousand RUB from 2.00 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 3.59% to 29.56 million RUB from 28.54 million RUB over 2022; cost of goods sold decreased by 3.46% to 16.73 million RUB from 17.33 million RUB; sales profit made up 490.00 thousand RUB compared to sales loss of 1.98 million RUB. 2022
Net loss (RAS) of MEDITSINSKIY TSENTR SOVREMENNAYA TERAPIYA, ZAO dropped over 2022 by 46.41% to 2.00 million RUB from 3.73 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 18.28% to 28.54 million RUB from 24.12 million RUB over 2021; cost of goods sold grew by 2.02% to 17.33 million RUB from 16.99 million RUB; sales loss decreased 2.46 times to 1.98 million RUB from 4.87 million RUB. 2021
Net loss (RAS) of MEDITSINSKIY TSENTR SOVREMENNAYA TERAPIYA, ZAO dropped over 2021 by 8.15% to 3.73 million RUB from 4.06 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 30.06% to 24.12 million RUB from 18.55 million RUB over 2020; cost of goods sold remained at the same level amounting to 16.99 million RUB compared to 16.94 million RUB; sales loss decreased by 9.56% to 4.87 million RUB from 5.38 million RUB. 2020
Net loss (RAS) of MEDITSINSKIY TSENTR SOVREMENNAYA TERAPIYA, ZAO increased by 0.77% to 4.06 million RUB from 4.03 million RUB over 2019, the company informed. Revenue increased in the accounting period by 19.13% to 18.55 million RUB from 15.57 million RUB over 2019; cost of goods sold grew by 3.49% to 16.94 million RUB from 16.37 million RUB; sales loss grew 1.56 times to 5.38 million RUB from 3.46 million RUB. 2019
Net loss (RAS) of MEDITSINSKIY TSENTR SOVREMENNAYA TERAPIYA, ZAO dropped over 2019 by 34.55% to 4.03 million RUB from 6.16 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 19.02% to 15.57 million RUB from 13.08 million RUB over 2018; cost of goods sold grew by 1.98% to 16.37 million RUB from 16.05 million RUB; sales loss decreased by 39.32% to 3.46 million RUB from 5.70 million RUB. 2018
Net loss (RAS) of MEDITSINSKIY TSENTR SOVREMENNAYA TERAPIYA, ZAO increased by 3.67% to 6.16 million RUB from 5.94 million RUB over 2017, the company informed. Revenue increased in the accounting period by 17.59% to 13.08 million RUB from 11.13 million RUB over 2017; cost of goods sold grew by 7.88% to 16.05 million RUB from 14.88 million RUB; sales loss grew by 2.76% to 5.70 million RUB from 5.55 million RUB. 2017
Net loss (RAS) of MEDITSINSKIY TSENTR SOVREMENNAYA TERAPIYA, ZAO dropped over 2017 by 33.37% to 5.94 million RUB from 8.91 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 11.33% to 11.13 million RUB from 9.99 million RUB over 2016; cost of goods sold decreased by 7.68% to 14.88 million RUB from 16.11 million RUB; sales loss decreased by 34.78% to 5.55 million RUB from 8.50 million RUB. 2016
Net loss (RAS) of MEDITSINSKIY TSENTR SOVREMENNAYA TERAPIYA, ZAO increased by 7.37% to 8.91 million RUB from 8.30 million RUB over 2015, the company informed. Revenue increased in the accounting period by 30.15% to 9.99 million RUB from 7.68 million RUB over 2015; cost of goods sold decreased by 5.24% to 16.11 million RUB from 17.00 million RUB; sales loss decreased by 34.79% to 8.50 million RUB from 13.04 million RUB. 2014
Net loss (RAS) of MEDITSINSKIY TSENTR SOVREMENNAYA TERAPIYA, ZAO increased 301.90 times to 12.68 million RUB from 42.00 thousand RUB over 2013, the company informed. Cost of goods sold grew 246.79 times to 9.38 million RUB from 38.00 thousand RUB; sales loss grew 266.68 times to 10.13 million RUB from 38.00 thousand RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|